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Integrin-mediatedadhesionplaysacentral role inTcell
trafficking and activation. Genetic inactivation of the
guanine nucleotide-binding (G) protein a-subunits
Ga12 and Ga13 resulted in an increased activity of
integrin leukocyte-function-antigen-1 in murine CD4+
T cells. The interaction with allogeneic dendritic cells
was enhanced, leading to an abnormal proliferative
response in vitro. In vivo, T cell-specific inactivation
of Ga12 and Ga13 caused lymphadenopathy due to
increased lymphnodeentryandenhancedTcell prolif-
eration, and the susceptibility toward T cell-mediated
diseases was enhanced. Mechanistically, we show
that in the absence of Ga12 and Ga13 the activity of
the small GTPases Rac1 and Rap1 was increased,
whereas signaling of the small GTPase RhoA was
strongly reduced. Our data indicate that locally
produced mediators signal through Ga12- and Ga13-
coupled receptors to negatively regulate cell polariza-
tion and adhesiveness, thereby fine-tuning T cell
trafficking, proliferation, and susceptibility toward
T cell-mediated diseases.
INTRODUCTION
Integrin-mediated adhesion plays a central role in T cell functions.
The integrin leukocyte-function-antigen-1 (LFA-1), for example, is
crucial for the formationof the immunological synapse, the interface
between antigen-loaded mature dendritic cells and naive T cells.
LFA-1 also mediates firm adhesion to high endothelial venules,
thereby allowing naive T cells to enter secondary lymphatic organs.
In addition, LFA-1 has been implicated in the control of lymphocyte
differentiation and proliferation, as well as in the regulation of T cell
effector functions (Mor et al., 2007; Smith et al., 2007).708 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.Given this multitude of LFA-1 functions, a precise under-
standing of the spatial and temporal control of the interaction
between LFA-1 and its cellular counter-receptors, the intercel-
lular adhesion molecules (ICAMs), is of great importance. In
naive T cells, LFA-1 is tethered to components of the actin cyto-
skeleton and thereby held in the inactive state with the result that
naive T cells are rounded and only mildly adhesive (Shimaoka
et al., 2002; van Kooyk et al., 1999). Activation of LFA-1 occurs
in response to a variety of extracellular signals, for example
stimulation of cytokine receptors, the TCR-CD3 complex, or
G protein-coupled receptors (GPCRs) (Kinashi, 2005). Best
studied among the latter are the chemokine receptors, which
have been shown to positively regulate LFA-1 through heterotri-
meric G proteins of the Gi family (Laudanna and Alon, 2006; Lau-
danna et al., 2002). The intracellular signaling cascades medi-
ating the effects of chemokines on integrin activation have
been shown to involve several monomeric GTPases such as
Rap1, Rac1, or RhoA (Mor et al., 2007). However, chemokine
receptors are probably not the only GPCRs contributing to the
regulation of integrin activity; T cells also express a variety of
other GPCRs, such as lysophospholipid or prostanoid receptors,
many of which have been implicated in the regulation of adhe-
siveness as well (Chun and Rosen, 2006; Matsuoka and Naru-
miya, 2007). In contrast to chemokine GPCRs, these receptors
couple not only to Gi but also to other G protein families such
as G12 (Riobo and Manning, 2005), but the role of this G protein
family in the regulation of T cell in vivo functions has not been
investigated so far.
The two members of the G12 family, G12 and G13, are ubiqui-
tously expressed and interact upon receptor-mediated activa-
tion with certain Rho guanine nucleotide exchange factors (Rho-
GEFs) (Fukuhara et al., 2001), which in turn mediate activation of
the small GTPase RhoA. Because of the embryonic lethality of
mice lacking the a-subunits of G12 and G13 (Ga12 and Ga13)
(Gu et al., 2002; Offermanns et al., 1997), and because of the
lack of specific inhibitors of these proteins, the relevance of
this family in the adult organism has long been elusive. The
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G Proteins of the G12 Family and T Cell FunctionsFigure 1. Lymphadenopathy in T-Ga12,Ga13 DKOs
(A) CD90.2+ T cells were isolated from lymph nodes of controls (LckCre/Gna13fl/flGna12+/) and T-Ga12,Ga13 DKOs (LckCre
+/Gna13fl/flGna12/) and sub-
jected to immunoblotting with antibodies directed against Ga13, Ga12 and a-tubulin as loading control.
(B) Weight of peripheral lymph nodes (n = 8).
(C) Leukocyte numbers per node (n = 8).
(D) Absolute numbers of CD45R/B220+ B cells as well as CD4+ and CD8+ T cells per node (n = 10).
(E) Immunohistochemical staining of T cells and B cells in inguinal lymph nodes with antibodies against CD90.2 and CD45R/B220.
(F) Percentage of BrdU-positive T cells in lymph nodes 4 hr after intraperitoneal injection of BrdU as determined by intracellular flow cytometry (n = 6).
(G) In vitro proliferation of 23 105 CD4+ T cells after 72 hr of culture with 53 104 CD11c+ allo-DCs, after TCR crosslinking with immobilized CD3-CD28 antibodies,
or after stimulation with staphylococcal enterotoxin B (10 ng/ml) (n = 6–10).
(H) The concentration of secreted cytokines was determined in the supernatant of cocultures between CD4+ T cell and allo-DC after 72 hr (n = 8).
White bars represent the control; black bars represent the T-Ga12,Ga13 DKO. Data are displayed as mean ± SEM. *p < 0.05; ***p < 0.0005.recent generation of tissue-specific Ga12,Ga13 double-deficient
mice revealed important functions in platelets and B cells (Moers
et al., 2003; Rieken et al., 2006a; Rieken et al., 2006b); the in vivo
role of Ga12 andGa13 in peripheral T cells, however, has not been
addressed up to now. With the help of the Cre-loxP system, we
generated T cell-specific Ga12,Ga13 double-deficient mice and
show here that these proteins negatively regulate the activation
state of integrin LFA-1, thereby modulating T cell trafficking and
proliferation, as well as responses to foreign and self antigen.
RESULTS
Lymphadenopathy in T Cell-Specific Ga12,Ga13
Double-Deficient Mice
T cell-specific Ga12,Ga13 double-deficient mice were generated
by intercrossing animals in which the gene coding for Ga13,
Gna13, was flanked by loxP sites (Gna13fl/fl) with the T cell-
specific Lck-Cre line (LckCre+/) and constitutively Ga12-defi-
cient (Gna12/) mice (Gu et al., 2002; Hennet et al., 1995;Moers
et al., 2003). As controls we used LckCre/Gna13fl/flGna12+/
littermates throughout the study. Immunoblots showed that
Ga13 immunoreactivity was strongly reduced and that Ga12
was absent in extracts of isolated CD90.2+ (Thy1.2) T cells
(Figure 1A). T cell-specific Ga12,Ga13 double-deficient micewere born at expected frequencies and were viable and fertile,
but showed an increased size and weight of axillary, cervical,
and inguinal lymph nodes (Figure 1B). Mesenteric lymph nodes
were enlarged as well, whereas Peyer’s patches appeared
normal (data not shown). The increased lymph node weight cor-
responded to increased cell numbers (Figure 1C), and flow cyto-
metric analysis of lymphocyte subpopulations revealed that this
was predominantly a result of an expansion of the CD4+ T cell
population (Figure 1D). The general organization into B cell folli-
cles and T cell areas was not disturbed (Figure 1E). The relative
numbers of CD4+ regulatory T cells and CD4+ memory-effector
T cells within lymph nodes were not altered (data not shown).
In addition to lymphadenopathy, T cell-specific Ga12,Ga13
double-deficient mice showed an increased thymic weight and
cell number, with a proportionate increase in all subpopulations
(Table S1 available online). There were no substantial differences
with respect to the expression of TCRb chain, CD33, CD69, or
CD5 in the different thymic subpopulations (data not shown).
The splenic weight and splenocyte numbers were increased,
although not significantly (p = 0.08 and 0.27, respectively). The
CD4+ T cell population in the blood was increased (Table S1).
Taken together, these results show that genetic inactivation of
Ga12 and Ga13 in T cells resulted in an increased cell number
especially of CD4+ T cells in lymph nodes, blood, and theImmunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc. 709
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G Proteins of the G12 Family and T Cell Functionsthymus, suggesting that these G proteins have regulatory func-
tions in CD4+ T cell proliferation, apoptosis, or trafficking.
Proliferation Is Enhanced in Ga12,Ga13 Double-Deficient
CD4+ T Cells
To study the causes of lymphadenopathy in T cell-specific
Ga12,Ga13 double-deficient mice, we investigated apoptosis
and proliferation. Apoptosis, here determined as the percentage
of Annexin V-positive T cells in freshly isolated lymph nodes, did
not differ between the genotypes (data not shown). To assess
basal T cell proliferation in lymph nodes, we determined the
percentage of 5-bromo-2-deoxyuridine (BrdU) incorporating
T cells 4 hr after intraperitoneal injection of BrdU. We found that
lymph nodes from mutant mice contained more BrdU-positive
CD4+ T cells than those from control animals, whereas the
proportion of BrdU-positive CD8+ T cells was not increased
(Figure 1F).Wenextdetermined in vitroproliferationbymeasuring
the incorporation of [3H]-thymidine into CD4+ T cells after 72 hr of
culture.Although therewasnodifference in theproliferationof un-
stimulatedCD4+ T cells,mutant cells showed an increased prolif-
eration in response to allogeneic splenic CD11c+ dendritic cells
(allo-DCs) (Figure 1G). In contrast, the proliferative response
induced by CD3-CD28 crosslinking, staphylococcal enterotoxin
B, or phorbol-12-myristate-13-acetate (PMA) did not differ
between the genotypes (Figure 1G and data not shown).
To test whether increased proliferation in response to allo-DCs
was accompanied by altered cytokine production, we deter-
mined cytokine amounts in the supernatant of cocultures
between CD4+ T cell and allo-DCs by ELISA. The production of
interleukin (IL)-2 was increased in mutant cells, whereas the
production of tumor necrosis factor-a (TNFa) or interferon-g
(IFNg) remained unchanged (Figure 1H). Taken together, these
results indicate that Ga12 and Ga13 negatively regulate CD4
+
T cell proliferation in response to allogeneic dendritic cells.
Ga12,Ga13 Double-Deficient CD4
+ T Cells Show
Enhanced Interaction with Dendritic Cells
Because theG12 family is known to contribute to the regulation of
cellular adhesiveness, we investigated whether the enhanced
proliferation in response to allo-DCs was due to abnormal cell-
cell interactions in mutant cells. Flow cytometric analysis of
conjugate formation between fluorescently labeled CD4+
T cells and allo-DCs revealed an increased interaction if the
CD4+ T cells were Ga12,Ga13 deficient (Figure 2A). We next
investigated the interaction between purified CD4+ T cells and
fluorescently labeled allo-DCs by live-cell imaging (Figure 2B
and Movies S1 and S2). In mutant CD4+ T cells, the proportion
of cells with stable DC interactions (‘‘stable’’ here defined as
an interaction that lasted throughout a 10 min movie) was
increased (Figure 2C andMovies S1 and S2), as well as the inter-
action between CD4+ T cells themselves (Figure 2D). These data
suggest an important role of Ga12 and Ga13 in the regulation of
cellular interactions between CD4+ T cells and allo-DCs.
LFA-1 Activity Is Increased in Ga12,Ga13
Double-Deficient CD4+ T Cells
To further investigate LFA-1 activity in mutant cells, we
compared adhesiveness of control and Ga12,Ga13 double-
deficient CD4+ T cells on ICAM-1- and VCAM-1 (vascular cell710 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.adhesion molecule-1)-coated plastic (Figure 3A). On ICAM-1,
mutant cells showed a higher basal adhesion than control cells,
whereas there was no difference with respect to basal adhesion
on VCAM-1. Mutant cells also showed increased ICAM-1 adhe-
siveness after integrin activation by chemokines or Mg2+ and
EGTA, whereas no differences were found in response to PMA
or TCR crosslinking (data not shown). On VCAM-1, none of these
integrin activators resulted in a substantial difference between
the genotypes (Figure 3A and data not shown).
LFA-1 activation has been shown to involve two modalities,
increased affinity and enhanced integrin clustering (Hogg et al.,
2002; Laudanna et al., 2002). To assess LFA-1 affinity, we deter-
mined binding of soluble ICAM-1 to CD4+ T cells in a flow cyto-
metric assay and found that in mutant T cells, the proportion of
cells that bound ICAM-1 was increased both under basal condi-
tions and after stimulation with Mg2+ and EGTA, which are
known to increase LFA-1 affinity (Figure 3B). We next investi-
gated LFA-1 clustering by immunofluorescent staining of the
Figure 2. Cell-Cell Interactions of Ga12,Ga13 double-deficient CD4
+
T Cells
(A) Flow cytometric analysis of dimer formation between CD4-PE-labeled
T cells and CD11c-FITC-labeled allo-DCs (n = 8).
(B) Live-cell imaging of isolated CD4+ T cells and CFSE-labeled allo-DCs.
Time-lapse movies of 10 min duration were recorded and exemplary micro-
graphs are depicted (magnification 403). The microphotographs taken at
0 min are overlaid with the GFP fluorescence image for identification of
CFSE-labeled DCs (marked by white arrows).
(C and D) Statistical evaluation of stable interactions between CD4+ T cells and
DCs (C) or between CD4+ T cells (D).
White bars represent the control; black bars represent the T-Ga12,Ga13 DKO.
Data are displayed as mean ± SEM. *p < 0.05.
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double-deficient CD4+ T Cells
(A) Adhesionof lymphnodeCD4+ T cells to ICAM-1-
or VCAM-1-coated plastic. The percentage of
adherent CD4+ T cells was determined by flow
cytometry after 30 min of incubation under basal
conditions as well as after stimulation with chemo-
kines CCL19 and 21 (CCL19+21) or Mg2++EGTA.
Data are expressed as percent of input (n = 8).
(B) Flow cytometric analysis of basal and
Mg2++EGTA-induced binding of fluorescently
labeled soluble ICAM-1 to CD4+ T cells (n = 6).
(C and D) Basal and CCL19+21-induced LFA-1
clustering inCD4+ T cells was determined by immu-
nofluorescent staining with an CD18 antibody.
(C) shows exemplary photomicrographs of CD18-
stained cells (magnification 633). (D) shows statis-
tical evaluation of the percentage of cells showing
CD18 clusters (n = 3).
(E) Effect of blocking antibodies directed against
LFA-1,a4b1, or isotype control onTcell-DC interac-
tions in live-cell imaging (n = 3).
(F) Effect of blocking antibodies directed against
LFA-1 on CD4+ T cell proliferation in response to
DCs (n = 6).
White bars represent the control; black bars repre-
sent the T-Ga12,Ga13 DKO. Data are displayed as
mean ± SEM. *p < 0.05.LFA-1 b-chain CD18 and found that the proportion of cells with
clusters was increased inmutant CD4+ T cells under basal condi-
tions and, less prominently, after chemokine stimulation (Figures
3C and 3D). However, because LFA-1 clustering was shown to
follow ligand binding (Kim et al., 2004), these findings might
represent a direct consequence of increased affinity. To exclude
that the observed differences were due to an increased surface
expression of LFA-1, we analyzed expression of the a- and b-
chains of LFA-1 by flow cytometry, but found no abnormalities
(data not shown). In order to test whether increased LFA-1
activity in Ga12,Ga13 double-deficient CD4
+ T cells altered integ-
rin outside-in signaling, we studied phosphorylation of extracel-
lular signal-regulated kinase (ERK) in response to Mn2+ and in-
tegrin crosslinking, but failed to detect differences between the
genotypes. Also, ERK phosphorylation in response to TCR
crosslinking or PMA was not altered (Figure S1).
To test whether increased interactions between mutant T cells
and allo-DCs were indeed due to increased LFA-1 activity, we
performed live-cell imaging in the presence of blocking anti-
bodies directed against LFA-1. Whereas LFA-1 antibodies had
only a minor effect on control CD4+ T cells, they normalized
enhanced interactions of Ga12,Ga13 double-deficient CD4
+
T cells. In contrast, a4b1 antibodies had no effect on either
control or mutant cells (Figure 3E). To further test whether
increased LFA-1 activity also contributed to enhanced prolifera-
tion of Ga12,Ga13 double-deficient CD4
+ T cells, we performed
in vitro proliferation assays with allo-DCs in the presence of
blocking antibodies directed against LFA-1. This treatment
reduced proliferation in mutant cells to the degree found in
control cells (Figure 3F), suggesting that deregulation of LFA-1activity importantly contributes to hyperproliferation of mutant
T cells. Taken together, these findings indicate that inactivation
of Ga12 and Ga13 results in CD4
+ T cells in an increased affinity
and avidity of LFA-1, which in turn leads to an increased interac-
tion with antigen-presenting cells.
Polarization and Migration in the Absence of Ga12
and Ga13
In addition to increased LFA-1 avidity and affinity, morpholog-
ical changes such as increased spreading might contribute to
increased adhesiveness in the absence of Ga12 and Ga13. To
investigate cell shape in vitro, we performed phalloidin stain-
ings of polymerized actin in ICAM-1 adherent CD4+ T cells.
We found that the proportion of cells with firmly attached rear
end and elongated tail was substantially increased in mutant
cells (Figures 4A and 4B), as was the percentage of polarized
cells (Figure 4C). To correlate these morphological changes
with potential changes in migratory behavior, we performed
time-lapse video microscopy of CD4+ T cells on ICAM-1-
coated plastic. The distance traveled by individual CD4+
T cells was decreased in the absence of Ga12,Ga13
(Figure 4D and Movies S3 and S4), whereas the proportion of
motile cells did not differ between the genotypes (Figure 4E).
We next investigated whether increased adhesiveness and
polarization would affect transmigration through transwell
inserts coated with ICAM-1 or bEND.3 endothelial cells. Under
basal conditions, mutant cells showed reduced transmigration
both through ICAM-1 and endothelial cells, although migration
in response to chemokines CCL19 and CCL21 was not
impaired (Figure 4F).Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc. 711
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CD4+ T Cells
(A) Exemplary photomicrographs taken from phal-
loidin-stained CD4+ T cells that have adhered for
20 min to ICAM-1-coated plastic in the absence
(basal) or presence of CCL19+21 (magnification
633).
(B) Statistical analysis of the percentage of cells
with attached, elongated rear (n = 3).
(C) Percentage of CD4+ T cells with a polarized
phenotype (showing one or more F-actin positive
pseudopods) (n = 3).
(D) The distance traveled by CCL19+21-stimu-
lated CD4+ T cells was determined on ICAM-1-
coated plastic in time-lapse microscopy.
(E) Percentage of motile CD4+ T cells (i.e., traveling
more than one body length per 10 min) (n = 3).
(F) Percentage of CD4+ T cells that have migrated
through ICAM-1-coated transwells inserts (left) or
inserts covered with a confluent monolayer of
bEND.3 endothelial cells (right) during 3 hr of incu-
bation without agonist in the lower chamber
(basal) or in response to CCL19+21 (n = 5).
White bars represent the control; black bars repre-
sent the T-Ga12,Ga13 DKO. Data are displayed as
mean ± SEM. *p < 0.05; **p < 0.005.Enhanced Lymph Node Entry of Deficient CD4+ T Cells
In addition to increased proliferation, LFA-1 hyperactivity in the
absence of Ga12 and Ga13 might affect T cell trafficking into
lymph nodes, thereby contributing to lymphadenopathy. To
study whether increased adhesiveness to ICAM-1 altered
T cell trafficking in vivo, we performed adoptive transfer experi-
ments with fluorescently labeled purified CD4+ T cells from
control and mutant mice. Twenty-four hours after injection,
significantly more mutant than control cells were found in
cervical lymph nodes of the respective host (Figure 5A). Because
this might be a result of altered entry and/or exit, we repeated
these experiments at 2 hr after transfer and found that even at
this time point, mutant CD4+ T cells were overrepresented
(Figure 5B). Also the entry of deficient CD4+ T cells into the
spleen was increased at two hours after transfer, whereas
numbers of mutant cells in the blood were reduced (Figure 5B).
Intravenous injection of LFA-1 antibodies into hosts 30 min prior
to adoptive transfer normalized the increased entry of Ga12,Ga13
double-deficient CD4+ T cells (Figure 5C), suggesting that
increased LFA-1 activity, but not disinhibition of other integrins
such as a4b1, underlies enhanced entry.
To investigate in vivo whether increased adhesiveness of
Ga12,Ga13 double-deficient CD4
+ T cells leads to a logjam of
cells within the lymphatic vessels or to the opposite, a more effi-
cient transendothelial migration, we performed two-photon
intravital microscopy of inguinal lymph nodes 2 hr after adoptive
transfer (Figures 5D and 5E). We determined the numbers of
control and Ga12,Ga13 double-deficient CD4
+ T cells in (1)
a vessel-rich zone, comprising mostly medulla, containing
higher-order venules and high endothelial venules (HEV), and
in (2) the T cell zone itself. Two hours after transfer, neither
control nor mutant CD4+ T cells were detected directly attached
to HEV endothelium; all cells had transmigrated through the
venule wall. Within the lymphatic tissue, the majority of cells
had already proceeded to dense lymphatic tissues, i.e., to the712 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.proper T cell zones. A minority of CD4+ T cells was found in
the vessel rich zone, where Ga12,Ga13 double-deficient cells
were overrepresented (Figure 5E). These findings indicate that
enhanced transendothelial migration without persistent attach-
ment to HEV is the main factor underlying the observed domi-
nance of Ga12,Ga13 double-deficient CD4
+ T cells in the lymph
node 2 hr after adoptive transfer.
To also address the question of potentially impaired lymph
node egress, we studied transwell migration of Ga12,Ga13
double-deficient CD4+ T cells in response to the GPCR agonist
sphingosine 1-phosphate (S1P), which has been shown to regu-
late egress from lymph node or thymus through the S1P1
receptor (Matloubian et al., 2004). However, neither with ICAM-
1-coated nor with uncoated transwell inserts did we observe
differences between the genotypes with respect to S1P-induced
migration (Figure 5F and data not shown), and such a finding is in
line with the assumption that S1P1 is a predominantly Gi-coupled
receptor (Chun and Rosen, 2006). To address the possibility of
an egress impairment independent of S1P, we analyzed the
percentage of dye-positive cells 24 hr after adoptive transfer in
the cisterna chyli, which collects efferent lymph from the lower
body. Also in cisterna chili lymph,mutant CD4+ T cells were over-
represented, suggesting that the passage time through lymph
nodes was not altered (Figure 5G). In summary, these results
show that increased LFA-1-mediated adhesion in Ga12,Ga13
double-deficient CD4+ T cells does not only result in an
enhanced interaction with allo-DCs but also facilitates entry
into lymph nodes.
Signaling Pathways Involved in Ga12,Ga13-Mediated
Regulation of LFA-1
We next attempted to elucidate the molecular mechanisms
underlying increased integrin activation and polarization in
Ga12,Ga13 double-deficient CD4
+ T cells. Small GTPases such
as Rap1, RhoA, and Rac1 are known to regulate integrin activity
Immunity
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(A–C) Differentially labeled CD4+ T cells from control and mutant mice were mixed in a 1:1 ratio and injected intravenously into wild-type recipients (5 3 106 per
mouse). After 24 (A) or 2 (B) hr, the proportion of labeled CD4+ T cells was determined by flow cytometry (data are corrected for actual input ratio as determined by
FACS). At 2 hr, spleen and blood were also investigated (n = 6–8). (C) shows the adoptive transfer into wild-type recipients pretreated with blocking LFA-1 anti-
bodies or isotype control (n = 4).
(D and E) Intravital two-photon microscopy was used for analyzing the distribution of control versus Ga12,Ga13 double-deficient CD4
+ T cells in the inguinal lymph
node 2 hr after adoptive transfer. (D) shows examples for the different areas studied (control cells in red, mutant cells in blue). (E) shows the statistical evaluation of
the percentage Ga12,Ga13 double-deficient CD4
+ T cells found in the two respective image zones and in FACS analysis of the transferred population (n = 3).
(F) Migration of control and mutant CD4+ T cells through uncoated transwell inserts in response to S1P.
(G) Proportion of dye-positive cells in cisterna chyli aspirates 24 hr after adoptive transfer.
White bars represent the control; black bars represent the T-Ga12,Ga13 DKO. Data are displayed as mean ± SEM. *p < 0.05.and cell polarization in response to chemokines (Iden and
Collard, 2008; Laudanna and Alon, 2006; Mor et al., 2007); we
therefore studied the activation state of these signaling mole-
cules in the absence of Ga12 and Ga13 (Figure 6). Both in control
and Ga12,Ga13 double-deficient cells, active Rap1 was barely
detectable in the basal state, but strongly increased 20 and
60 s after application of CCL19 and CCL21, and this increase
was even more prominent in Ga12,Ga13 double-deficient cells
(Figure 6A).
Although the potential interactions between the G12 family and
Rap1 still need to be elucidated, the small GTPase RhoA is
a well-known effector of G12 and G13. We studied RhoA activa-
tion in response to stimulation of known G12,G13-coupled recep-
tors such as the TXA2 receptor TP (Matsuoka and Narumiya,
2007) or LPA receptors (Chun and Rosen, 2006) and found that
the TP agonist U46619, as well as LPA, induced a robust RhoA
activation in control CD4+ T cells, but not in Ga12,Ga13 double-
deficient CD4+ T cells (Figure 6B). Interestingly, also basal
RhoA activity was reduced in Ga12,Ga13 double-deficient cells.
Given that RhoA has been shown to negatively regulate Rac1
(Iden and Collard, 2008), we next studied basal and chemo-
kine-induced Rac1 activation. We found that Rac1 activation
was generally enhanced in mutant cells, most prominently at
60 s after stimulation, but also under basal conditions
(Figure 6C). The G12,G13-mediated signaling pathway obviously
exerts an inhibitory effect on chemokine-induced Rac1 activa-
tion, and two different scenarios might underlie this finding:(1) CCR7 directly activates G12 and G13 in parallel with its main
effector pathway Gi, or (2) the CCR7-Gi-Rac1 signaling cascade
is modulated by other receptors than CCR7. To address the first
possibility, we investigated whether CCL19 and CCL21 were
able to induce RhoA activation in T cells and whether this de-
pended on Gi and/or on G12 and G13 (Figure 6D). We found
that CCL19+21 induced a mild RhoA activation in control
T cells, but the response was weaker and slower than that
induced by the TXA2 analog U46619. Pretreatment with
pertussis toxin, which ADP-ribosylatesGi and thereby uncouples
it from receptors, did not affect U46619-induced RhoA activation
but abrogated chemokine-induced RhoA activation. In
Ga12,Ga13 double-deficient T cells, U46619-induced RhoA acti-
vation was clearly reduced, whereas RhoA activation in
response to CCL19+21 was not changed compared to control
cells (Figure 6D). These findings indicate that the mild RhoA acti-
vation observed after CCR7 stimulation is rather mediated
through G proteins of the Gi family than the G12 family.
To investigate the potential involvement of other GPCRs in this
context, we tested whether concomitant activation of the
G12,G13-RhoA pathway, for example in response to U46619,
was able to quench chemokine-induced Rac1 activation in
wild-type cells. We found that coapplication of U46619 with che-
mokines induced a strong RhoA activation within 20 s (Figure 6E)
and that Rac1 activation was concomitantly reduced (Figure 6F).
Of note, the quenching effect of U46619 on chemokine-induced
Rac1 activation was abrogated in Ga12,Ga13 double-deficientImmunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc. 713
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G Proteins of the G12 Family and T Cell FunctionsFigure 6. Signaling Pathways Involved in Ga12,Ga13-Mediated Regulation of Adhesiveness and Polarization
(A) Basal andCCL19+21-induced Rap1 activation in control andGa12,Ga13 double-deficient T cells. The left panel shows exemplary immunoblots. The right panel
shows the statistical evaluation of the densitometric quantification (n = 5).
(B) Amounts of active, GTP-bound RhoA under basal conditions and 1 min after stimulation with the TXA2 analog U46619 or lysophosphatidic acid (LPA)
(n = 6–10).
(C) Basal and CCL19+21-induced Rac1 activation in CD4+ T cells (n = 6–10).
(D) Comparison of relative RhoA activation in response to U46619 and CCL19+21 in control T cells, pertussis toxin (PTX)-pretreated T cells, and Ga12,Ga13
double-deficient T cells (n = 3).
(E and F) Effect of U46619 on CCL19+21-induced activation of RhoA (E) and Rac1 (F) (n = 4–6).
(G) Effect of U46619 on conjugate formation between control or mutant CD4+ T cells and allo-DCs as determined by flow cytometry (n = 5).
(H) Effect of U46619 on allo-CD11c+-induced proliferation in control CD4+ T cells, as well as CD4+ T cells deficient for Ga12,Ga13 (Gna12
/,Gna13/), Lsc
(Arhgef1/), or LARG (Arhgef12/) (n = 3–5).
(I) Effect of LPA and S1P on allo-CD11c+-induced proliferation in control and Ga12,Ga13 double-deficient CD4
+ T cells (n = 3–5).
White bars represent the control; black bars represent the T-Ga12,Ga13 DKO. s, seconds. Data are displayed as mean ± SEM. *p < 0.05.714 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.
Immunity
G Proteins of the G12 Family and T Cell FunctionsFigure 7. Immune Responses in T-Ga12/13 DKOs
(A–C) Delayed type hypersensitivity. (A) shows an increase in ear thickness after sensitization and challenge with DNFB (n = 10). (B) and (C) show flow cytometric
analysis of BrdU-positive CD4+ T cells (B) and of CD4+,CD44+,CD62L effector and memory T cells (C) in cervical lymph nodes 72 hr after challenge (n = 6).
(D–F) MLD-STZ-induced diabetes mellitus. (D) shows urine glucose amounts at different time points after disease induction (n = 10). (E) shows flow cytometric
analysis of BrdU-positive CD4+ T cells in peripancreatic lymph nodes before onset of symptoms (days 5–6) and in the late phase of disease (day 14) (n = 4).
(F) shows flow cytometric analysis of pancreatic infiltrates at days 5–6 and day 14 (n = 4–6). White bars represent the control; black bars represent the
T-Ga12,Ga13 DKO. Data are displayed as mean ± SEM. *p < 0.05.Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc. 715cells (Figure 6F), in which RhoA activation was strongly reduced
(Figure 6E).
We next asked whether U46619-induced activation of the
G12,G13-RhoA-signaling cascade would also affect cell-cell inter-
actions and, secondary to that, proliferation. We found that
U46619 reduced dimer formation between control CD4+ T cells
and allo-DCs, whereas it moderately increased conjugate forma-
tion in Ga12,Ga13 double-deficient CD4
+ T cells (Figure 6G).
Furthermore, U46619 reduced in vitro proliferation of control
CD4+ T cells, and this effect was impaired in mutant cells
(Figure 6H). We next investigated the potential involvement of the
G12,G13-regulated RhoGEF proteins Lsc-p115RhoGEF (Lsc) and
leukemia-associated RhoGEF (LARG) in this process and found
that U46619-induced suppression of proliferation was reduced
in Lsc-deficient cells as well (Figure 6H). Also, inactivation of
LARG led to some reduction, although a less prominent one, sug-
gesting that both LARG and Lsc contribute to the effects of
Ga12,Ga13 on adhesiveness and proliferation, with a predominant
role of Lsc (Figure 6H). Interestingly, lysophospholipids LPA and
S1P also were able to reduce proliferation in response to allo-
DCs in a Ga12,Ga13-dependent manner (Figure 6I). Of note, the
inhibitory effects of U46619, LPA, and S1P on proliferation are
mild compared to the effect of LFA-blocking antibodies, showing
that the G12,G13-mediated signaling pathway only exerts a modu-
lating role. Taken together, these results suggest thatGPCRssuch
as the TXA2 receptor, but also LPA and S1P receptor subtypes,
negatively regulate cell adhesion and polarization through
G12,G13-mediated activation of RhoA, which in turn modulates
chemokine-induced activation of Rac1, and, directly or indirectly,Rap1 (Figure S2).Wehypothesize that TXA2 or LPA regulate adhe-
sivenessofCD4+Tcells inanauto-orparacrinemanner; insupport
of this hypothesis, we found that gentlewashing of cells enhanced
ICAM-1 adhesion, but not VCAM-1 adhesion (Figure S3).
Immune Functions In Vivo
Increased CD4+ T cell proliferation and trafficking might alter
responses to exogenous or endogenous antigens, resulting in
abnormal immune responses or autoimmune disease. Neither
routine histological analysis of internal organs nor staining for
IgG deposition in the kidney of aged mice revealed signs of
spontaneous autoimmune disease (data not shown), which led
us to challenge T cell-specific Ga12,Ga13 double-deficient mice
in twomodels of T cell-mediated pathology: contact hypersensi-
tivity to dinitrofluorobenzene (DNFB) as amodel for responses to
foreign antigen (Kurimoto and Streilein, 1993) and low-dose
streptozotocin-induced diabetes mellitus as a model of autoim-
mune disease (Like and Rossini, 1976).
During the sensitization phase of contact hypersensitivity, the
hapten DNFB is applied to the abdominal skin from where it is
transported to draining lymph nodes and presented by dendritic
cells. The resulting activation of naive T cells and generation of
effector cells leads during the elicitation phase (rechallenge
with DNFB in the ear of the skin) to leukocyte recruitment to
the ear, resulting in a Th1-cell-dependent local inflammation
with consecutive swelling (Kurimoto and Streilein, 1993). We
found that T cell-specific Ga12,Ga13 double-deficient mice
showed increased ear swelling at 24, 48, and 72 hr after sensiti-
zation and challenge (Figure 7A), and histological analyses of ear
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tion (data not shown). Basal ear thickness and histology did
not differ between the genotypes (data not shown). CD4+
T cells in cervical lymph nodes from mutant mice showed
a higher proliferation rate than those of control mice (Figure 7B),
and the proportion of T memory and effector cells was increased
(Figure 7C).
In the second in vivo model, type I diabetes mellitus is induced
by intraperitoneal administration of multiple low doses of strep-
tozotocin (MLD-STZ), and the pathogenesis of this disease has
been shown to involve an autoimmune-mediated destruction
of pancreatic b-cells (Like and Rossini, 1976). We determined
urine glucose levels every 72–96 hr starting from the seventh
day after diabetes induction and found that in deficient mice dia-
betes development was both accelerated and aggravated
(Figure 7D). Because this might be due to an increased prolifer-
ative response to an altered cytokine profile, or to increased
entry into inflamed tissues, we investigated proliferation, cyto-
kine production and number of infiltrating leukocytes before
onset of symptoms (days 5–6) and at the height of disease
(day 14). We found that peripancreatic lymph nodes were clearly
enlarged already at day 5–6 (total cell number control mice: 9.8 ±
3.4 3 106, mutant mice: 25.9 ± 5.8 3 106); the CD4+ T cells
showed enhanced proliferation (Figure 7E) without substantial
changes in the production of IFNg, TNFa, or IL-4 (data not
shown). The numbers of pancreas-infiltrating CD4+ T cells,
CD8+ T cells, or CD11b+ macrophages did not differ between
the genotypes at days 5–6; at day 14, however, T cell-specific
Ga12,Ga13 double-deficient mice showed increased numbers
of pancreas-infiltrating CD4+ T cells (Figure 7F and data not
shown). Taken together, these findings show that the enhanced
proliferative responses in T cell-specific Ga12,Ga13 double-defi-
cient mice are associated with an increased susceptibility and
severity of T cell-mediated diseases.
DISCUSSION
Whereas Gi-coupled chemokine receptors have in many studies
been shown to importantly contribute to T cell trafficking or
formation of the immunological synapse (Kinashi, 2005; Lau-
danna et al., 2002), the role of the G12 family in peripheral
T cells is poorly understood. We report here that Ga12,Ga13
double-deficient CD4+ T cells show an enhanced interaction
with allo-DCs, thereby leading to abnormal proliferative
responses in vitro. Together with an increased lymph node entry,
this enhancement of proliferation most likely underlies the
increased lymph node size observed in T cell-specific
Ga12,Ga13 double-deficient mice in vivo. Our in vitro studies
suggest an increased activity of integrin LFA-1 as an underlying
mechanism, and this notion is strongly supported by the finding
that blocking antibodies directed against LFA-1 normalized
T-DC interactions and in vitro proliferation and increased lymph
node entry of Ga12,Ga13 double-deficient T cells. Also the fact
that hyperproliferation is only observed in response to adhe-
sion-dependent stimulation by DCs, but not in response to direct
stimulation of the T cell receptor (TCR), PMA, or superantigens,
points to the important role of LFA-1 in this context.
The increased adhesiveness observed in the absence of Ga12
and Ga13, however, is moderate compared to that observed in716 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.a mouse line carrying a hyperactive LFA-1 mutant (ItgalD/D) con-
taining a five amino acid deletion in the membrane-proximal
region of LFA-1 (Semmrich et al., 2005). ItgalD/D lymphocytes
share with Ga12,Ga13 double-deficient cells in vitro phenotypes
such as increased ICAM-1 adhesion, impaired transmigration,
and tail retraction, but they differ considerably with respect to
their in vivo phenotype. In vivo, ItgalD/D mice resemble LFA-1-
deficient animals, with reduced lymph node and thymus sizes
and impaired proliferative responses (Berlin-Rufenach et al.,
1999; Schmits et al., 1996). These paradoxical findings are
most likely due to the constitutive active nature of the ItgalD/D
mutant, and this nature leads to irrevocable attachment to
HEV or DCs and thereby prevents normal transmigration or acti-
vation. In Ga12,Ga13 double-deficient T cells, in contrast, nega-
tive regulation of LFA-1 through other mechanisms such as
cbl-b (Zhang et al., 2003) or RhoH (Cherry et al., 2004) is still
functional, leading to the observed moderate changes in traf-
ficking and proliferation.
Our in vitro studies suggest that the inactivation of Ga12 and
Ga13 results in an altered activation state of three small GTPases
involved in the regulation of polarization and integrin-mediated
adhesion: RhoA, Rac1, and Rap1. RhoA has been shown to
regulate integrin activity in T cells both positively (Constantin
et al., 2000; Giagulli et al., 2004) and negatively (Rodriguez-Fer-
nandez et al., 2001; Smith et al., 2003); in addition, it has been
involved in polarization (Iden and Collard, 2008; Mor et al.,
2007). RhoA is probably the most important effector of Ga12
and Ga13, but it should be kept in mind that RhoA can also be
activated by a variety of other signaling pathways such as integ-
rins, receptor tyrosine kinases, plexins, or Gq and Gi family
G proteins. RhoA activation in response to stimulation of
G12,G13-coupled receptors is mediated by three specific
RhoGEF proteins, Lsc, LARG, and PDZ-RhoGEF (Fukuhara
et al., 2001), and our data indicate that Lsc, and to a lesser extent
also LARG, mediate the inhibitory effects of Ga12 and Ga13 on
adhesion and proliferation. In line with these findings, Lsc-defi-
cient mice share some phenotypical aspects with T cell-specific
Ga12,Ga13 double-deficient mice, for example increased lymph
node size and in vitro proliferation (Girkontaite et al., 2001) or
impaired rear detachment from ICAM-1 (Rubtsov et al., 2005).
An increased polarization was also observed in Ga12,Ga13
double-deficient B cells (Rieken et al., 2006b) or in neutrophils
expressing dominant-negative forms of Ga12 and Ga13 (Xu
et al., 2003). Xu et al. (2003) suggested that chemoattractant
receptors might activate Gi- and G12,G13-mediated signaling
pathways in neutrophils in parallel, whereas our data suggest
that G12,G13-mediated quenching of chemokine-induced Rac1
activity involves receptors other than CCR7, for example, TP.
RhoA is known to antagonistically regulate Rac1, a small
GTPase involved in the regulation of cellular morphology, polar-
ization, and integrin signaling (Iden and Collard, 2008; Mor et al.,
2007). We found that both basal and chemokine-induced Rac1
activation is increased in the absence of Ga12 and Ga13, possibly
contributing to enhanced polarization and integrin-mediated
adhesion of Ga12,Ga13 double-deficient T cells (D’Souza-
Schorey et al., 1998; Garcia-Bernal et al., 2005). We furthermore
show that chemokine-induced Rac1 activation in control CD4+
T cells is dampened by concomitant simulation of the G12,G13-
RhoA pathway through the TP agonist U46619. Interestingly,
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Gq family (Gratacap et al., 2001); it seems, however, that during
combined application of U46619 and CCL19+21, the G12,G13-
RhoA mediated inhibition of Rac1 outweighs Gq-induced Rac1
activation. Importantly, stimulation of the G12,G13-RhoA
signaling cascade by U46619 does not only impede
CCL19+21-induced Rac1 activation but also impacts on adhe-
siveness and, consecutively, on proliferation: U46619 is able to
reduce conjugate formation between wild-type CD4+ T cells
and allo-DCs, resulting in reduced proliferation in vitro. Of note,
the Ga12,Ga13-mediated modulation of adhesiveness and prolif-
eration was not restricted to U46619, but was also observed in
response to LPA and, to a lesser extent, S1P. We therefore
hypothesize that local mediators such as S1P, LPA, and TXA2
are released from lymphocytes or bystanding cells andmodulate
cell polarization and integrin-mediated adhesion in an auto- or
paracrine manner. Lysophospholipids and TXA2 are released
from blood cells, macrophages, and dendritic cells (Chun and
Rosen, 2006; Kabashima et al., 2003) and are therefore likely
to contribute to the regulation of cell-cell interactions during
lymph node entry or antigen presentation. Genetic inactivation
of the TXA2 receptor TP, for example, resulted in age-dependent
lymphadenopathy and enhanced immune responses to foreign
antigens (Kabashima et al., 2003). In line with an important role
of Ga12 and Ga13 in the negative regulation of adhesiveness
through auto- and paracrine factors, we found that gentle
washing significantly increased ICAM-1 adhesiveness in control
but not in Ga12,Ga13 double-deficient T cells.
The third GTPase that shows altered activation in the absence
of Ga12 and Ga13 is Rap1, which has been shown to increase
integrin-mediated adhesion (Katagiri et al., 2000; Sebzda et al.,
2002), for example in response to chemokine receptor activation
(Shimonaka et al., 2003). Whether increased chemokine-
induced Rap1 activation in the absence of Ga12 and Ga13 is
causally related to increased Rac1 and impaired RhoA activation
is currently unclear. Crosstalk between Rac1 and Rap1 has been
implicated in the regulation of cell migration, for example by
localizing GEFs for Rap1 and Rac1 to the ruffling membrane
(Arthur et al., 2004; Caloca et al., 2004), but the effects of
Ga12,Ga13 on Rap1 and Rac1 might also be independent.
A fourth GTPase involved in the regulation of LFA-1 activity in
lymphocytes is RhoH (Cherry et al., 2004). In contrast to other
small GTPases, RhoH is GTPase deficient and therefore does
not undergo the normal activation-inactivation cycle; instead, it
was suggested to be regulated on the transcriptional level (Li
et al., 2002). We investigated RhoH expression by RT-PCR but
did not find altered expression in the absence of Ga12 and
Ga13 (data not shown), suggesting that altered RhoH expres-
sion does not contribute to the phenotype of T cell-specific
Ga12,Ga13 double-deficient mice.
Interestingly, whereas LFA-1 activity is clearly enhanced in
Ga12,Ga13 double-deficient CD4
+ T cells, the activation state of
integrin a4b1 is not altered, suggesting that these integrins are
differentially regulated. A differential regulation of a4b1 and
LFA-1 by small GTPases has been described in a rat monocytic
cell line (Honing et al., 2004) and in human T cells (Ghandour
et al., 2007); the underlyingmechanisms, however, are unknown.
It is also currently unclear why Ga12,Ga13 deficiency seems to
affect CD4+ T cells more prominently than CD8+ T cells. Differ-ences in the expression of G12 family G proteins or of G12,G13-
coupled receptors might explain these findings, but neither in
literature (Chun and Rosen, 2006; Kabashima et al., 2003) nor
in our own experiments did we find evidence for such differ-
ences. It might be speculated that not yet characterized
G12,G13-coupled receptors with cell type-specific expression
are involved in the negative regulation of integrin activity.
The in vivo relevance of the G12,G13-mediated negative regu-
lation of LFA-1 is clearly documented by the finding that T cell-
specific Ga12,Ga13 double-deficient mice show an increased
susceptibility toward endogenous and exogenous antigens, re-
sulting in increased severity of autoimmune diabetes and cuta-
neous hypersensitivity. Interestingly, except for the increased
lymph node size, we did not detect signs of spontaneous auto-
immune disease in T cell-specific Ga12,Ga13 double-deficient
mice, suggesting that the regulatory effect of Ga12 and Ga13 is
especially important under pathological conditions.
Taken together, our data show that heterotrimeric G proteins
of the G12 family negatively regulate the activation state of integ-
rin LFA-1, thereby fine-tuning T cell trafficking, proliferation, and
susceptibility toward immune disease. We show that a variety of
receptor systems such as lysophospholipid or prostanoid recep-
tors converge on Ga12 and Ga13 to modulate activation of RhoA,
Rac1, Rap1, and ultimately LFA-1, and it is well possible that
other, yet unknown mediators contribute to this process. There-
fore, a cell-type-specific manipulation of Ga12 and Ga13 or of
downstream RhoGEF proteins might in the future prove useful
tomodulate T cell trafficking or the strength of the immunological
synapse.
EXPERIMENTAL PROCEDURES
Animals and Cells
Mice were housed under specific pathogen-free conditions, and their genetic
background was predominantly C57BL6/N (fifth generation backcross).
Genotyping was performed as described previously (Moers et al., 2003). For
generation of conditional LARG-deficient mice, please see Supplemental
Experimental Procedures. Untouched lymph node CD4+ T cells and splenic
CD11c+ dendritic cells were isolated with the mouse CD4+ T cell isolation kit
or mouse CD11c-Microbeads, respectively (Miltenyi, Bergisch-Gladbach,
Germany). All animal experiments have been approved by local authorities.
Chemicals and Antibodies
U46619 was from Cayman (Ann Arbor, MI, USA); LPA and S1P were from Bio-
mol (Hamburg, Germany), chemokines from PeproTech (London, UK); and
STZ, DNFB, staphylococcal enterotoxin B, and a-tubulin antibodies were
from Sigma-Aldrich (St. Louis, MO, USA). Endotoxin-free antibodies against
LFA-1, VLA4, or isotype control were from the Cancer Research UK Mono-
clonal Antibody Unit, London. Antibodies against Ga13, Ga12, and LARG
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All other anti-
bodies were from BD Biosciences (San Jose, CA, USA).
Flow Cytometry
All flow cytometric analyses were performed with a FACSCalibur flow cytom-
eter and CellQuestPro Software (BD Biosciences). Apoptosis and proliferation
were determined with the Annexin-V-FITC apoptosis kit and the FITC-BrdU
flow kit, respectively; intracellular cytokine production was determined with
the mouse intracellular cytokine staining kit (all BD Biosciences). For the
flow cytometric analysis of conjugate formation, 1 3 105 PE-labeled CD4+
T cells and 1 3 105 FITC-labeled CD11c+ DCs were mixed, centrifuged for
1 min at 50 3 g, and incubated for 20 min. After gentle resuspension, the
proportion of CFSE-PE double-positive events was determined.Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc. 717
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For live-cell imaging, 105 unstained purified CD4+ T cells from control or
mutant mice were mixed with 2 3104 CFSE-labeled CD11c+ DCs in a droplet
of 20 ml RPMI1640, 10 mM HEPES, and 10% FCS and allowed to attach to
CELL STAR plastic dishes (Greiner Bio-One GmbH, Essen, Germany) for 20
min at 37C and 5% CO2. In some cases, 10 mg/ml LFA-1 antibodies, 10 mg/
ml a4b1 antibodies, or 10 mg/ml isotype control were added to the mixture.
Cell interactions were recorded for 10 min with a Leica DM IRE2 inverted fluo-
rescence microscope and Leica FW4000 software at 37C and 5% CO2 (1
frame per 10 s). For statistical analysis, cell interactions were classified by
an investigator blinded to genotype; an interaction was classified as stable if
it lasted throughout a 10 min movie. In some cases, plates were coated with
ICAM-1 (for coating, see Adhesion Assays) and the distance traveled by indi-
vidual T cells was determined with the ImageJ program (NIH, Bethesda, MD,
USA).
Adhesion Assays
Adhesion assays were carried out in 48-well plastic dishes as described previ-
ously (Rieken et al., 2006a), with minor modifications: for ICAM-1 coating,
wells were coated with 50 mg/ml goat-anti-human-IgG-Fc antibody (Jackson
ImmunoResearch, West Grove, PA, USA) at 4C overnight, washed twice
with PBS, and incubated with 2.5 mg/ml mouse ICAM-1-Fc (R&D Systems,
Minneapolis, USA) in PBS for 2 hr. For VCAM-1 coating, wells were incubated
for 1 hr at 37C with 3 mg/ml hVCAM-1 (R&D Systems) in carbonate buffer. In
some cases, chemokines CCL19 and 21 were added at final concentrations of
100 ng/ml during ICAM-1 and hVCAM-1 coating. Afterward, all wells were
blocked with 0.5% bovine serum albumine (BSA) in PBS for 30 min before
use. The volume per well was 100 ml in each step. For the adhesion assay,
5 3 105 lymph node cells were incubated in 100 ml RPMI1640 containing
10 mMHEPES and 0.5% FCS for 30 min at 37C and 5% CO2; in some cases,
CCL19 and CCL21 (100 ng/ml final), Mg2+ (10 mM) and EGTA (1 mM), CD3-
CD28 antibodies (5 mg/ml each), or PMA (5 ng/ml) were added. After discarding
nonadherent cells, the plate was gently washed in PBS and adherent cells
were subsequently detached in RPMI1640, 5 mM EDTA for 20 min on ice.
Numbers of adherent CD4+ T cells were determined after antibody staining
by flow cytometry, and data are displayed as the proportion of adherent cells
relative to cell input into the adhesion assay.
Soluble ICAM-1 Binding
Binding of ICAM-1 (10 mg/ml, R&D Systems) to CD4+ T cells in the absence or
presence of 10mMMg2+ and 1mMEGTAwas determined as described previ-
ously (Sebzda et al., 2002). In brief, freshly isolated lymph node cells (1 3 105
cells/ml) were resuspended in HEPES buffer (20 mM HEPES, 140 mM NaCl,
and 2 g/l glucose) with 0.1% BSA at a concentration of 2 3 106 cells/ml.
Lymphocyte aliquots of 50 ml (1 3 105 cells) were added to 96-well plates
with or without 10 mM Mg2+ and 1 mM EGTA. Soluble murine ICAM-1Fc
(10 mg/ml, R&D Systems) was added to the cells. After 30 min incubation at
37C, cells were washed twice in ice-cold PBS with 0.1% BSA and incubated
with Fc-specific FITC-conjugated goat anti-human IgG (1:200; Jackson Immu-
noresearch, West Grove, PA, USA) and PerCP-conjugated anti-mouse CD4
antibody for 10 min on ice. We washed cells twice in PBS with 0.1% BSA to
remove excess unbound antibodies and detected fluorescence by flow
cytometry.
Migration Assays
For chemotaxis assays, lymph node cells were preincubated in RPMI1640 +
10 mM HEPES + 0.1% BSA for 30 min at 37C and 5% CO2 and then allowed
to migrate through 5 mm pore size transwell inserts (Corning, Acton, MA, USA)
at a density of 23 106 splenocytes/100 ml per well. The transwell inserts were
uncoated, ICAM-1-coated (as described for Adhesion Assays), or seeded with
3 3 104 bEND.3 endothelial cells (from ATCC [Montesano et al., 1990]) 24 hr
before the experiment. The lower wells contained either 600 ml RPMI1640 +
10 mM HEPES + 0.1% BSA alone or medium plus 100 ng/ml CCL19+21, or
1–100 nM S1P. After 3 hr of incubation at 37C and 5% CO2, transwell plates
were kept on ice for 20 min and centrifuged at 180 3 g for 3 min, inserts were
discarded, and cells were stained for CD4+ T cells and counted by flow cytom-
etry. Cell numbers were expressed as a proportion of input. All experiments
were done in triplicates.718 Immunity 30, 708–720, May 22, 2009 ª2009 Elsevier Inc.Adoptive Transfer Experiments
Fluorescent labeling of cells with the Cell Trace CFSE Cell Proliferation Kit
(50 nM CFSE final), CellTracker CM-DiI (5 mM final), or SNARF (500 nM final)
(all Invitrogen, Karlsruhe, Germany) was performed according to the manu-
facturer’s instructions. For adoptive transfer experiments, isolated CD4+
T cells from mutant and control animals were labeled with CFSE and DiI, or
SNARF, mixed in a 1:1 ratio, and injected intravenously (5 3 106 cells per
mouse). In some cases, recipients were pretreated with 100 mg LFA-1 anti-
bodies or isotype control. After 2 or 24 hr, the proportion of CFSE- and DiI-
positive cells in cervical lymph nodes was analyzed by flow cytometry; in
some cases we also analyzed cisterna chyli punctate. All data were corrected
for the actual input ratio as determined by FACS.
RhoA, Rac1, and Rap1 Activation Assays
Amounts of GTP-bound RhoA or Rac1 were determined with RhoA or Rac1
G-LISA activation kits (Cytoskeleton, Denver, CO, USA), and Rap1 was de-
tected with the EZ-Detect Rap1 activation kit (Pierce, Rockford, USA). For
each measurement, 2 3 106 (RhoA) or 5 3 106 (Rac1, Rap1) T cells were
used; in some cases, cells were pretreated with PTX 100 ng/ml. Agonist
concentrations were 1 mM for U46618 and 100 ng/ml for chemokines.
Intravital Two-Photon Microscopy
Three-dimensional two-photon microscopywas performed with aMaiTai laser
(Spectra-Physics, Darmstadt, Germany) running at 800 nm, amultibeam scan-
head (LaVision Biotech, Bielefeld, Germany), and an Olympus BX51WI micro-
scopic stage equipped with a XLUMPL 320, NA 0.95 water dipping lens.
Image detection was done with a cooled CCD-camera (Imager Intense, LaVi-
sion, Goettingen, Germany). RGB Z stacks of 300 3 300 mm images were re-
corded in typically 15 steps of 3 mm. Frames taken at two to three positions
within each of the two imaging areas (vessel-rich zone [medulla, paracortex]
and T cell zone) were analyzed (Sanna et al., 2006). Rendering of video
sequences was performed with Volocity 4.3 (Improvision, Waltham, MA,
USA). Cell tracking was done with computer-assisted manual tracking with
CellTracker. Data were plotted with Prism 4 (GraphPad Software, San Diego,
CA, USA). Swapping of dyes resulted in the same findings. For details, see
Supplemental Experimental Procedures.
Animal Models
Delayed type hypersensitivity andMLD-STZ diabetes mellitus were induced in
female (DTH) or male (MLD-STZ) mice aged 8–16 weeks as described previ-
ously (Kurimoto and Streilein, 1993; Like and Rossini, 1976). Urine glucose
levels were determined with the glucose hexokinase method (Randox Labora-
tories, UK). For the flow cytometric quantification of pancreatic leukocyte
infiltration, the peripancreatic lymph nodes were carefully removed; then pan-
creata were minced and digested for 10–15 min at 37C under vigorous
shaking in Krebs-Ringer solution containing 0.5 mg/ml Collagenase P (Roche
Diagnostics, Mannheim, Germany). Leukocytes were then purified via Percoll
and Lympholyte M gradients (Cedarlane, Burlington, Canada) according to the
manufacturer’s instructions and analyzed by flow cytometry.
In Vitro Proliferation Assays, Immunoblotting,
and Immunohistochemistry
In vitro proliferation assays, immunoblotting, and immunohistochemistry were
performed as described previously (Rieken et al., 2006a; Rieken et al., 2006b).
For details, see Supplemental Experimental Procedures.
Statistics
Data are displayed as mean ± SEM. Comparisons between two groups were
performed with unpaired t test. n indicates the number of animals per experi-
mental group.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, one
table, three figures, and four movies and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00183-6.
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